Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 17, 2025 07:07 ET | Source: Pluristyx, Inc.

Pluristyx Collaborates with Breakthrough T1D to Make “Immune-Cloaked” and Safety Switch-Enabled Allogeneic Cell Line for Type 1 Diabetes Therapies

Pluristyx and Breakthrough T1D partner to engineer an immune-cloaked, safety-enabled iPSC line to advance universal islet therapies for type 1 diabetes.
November 10, 2025 07:25 ET | Source: Dyadic International, Inc.

Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics

Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics
October 31, 2025 08:06 ET | Source: Research and Markets

Asia-Pacific Cell Sheet-based Gene Therapy Market Trends and Growth Outlook 2025-2035 - Increasing Focus on Personalized Medicine and Precision Therapies is Creating Demand for Novel Cell-based Platforms

Dublin, Oct. 31, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Cell Sheet-based Gene Therapy Market: Focus on Technology Type, Cell-sheet Type, Source Type, Application Type, End User, and Country -...
October 31, 2025 08:03 ET | Source: Research and Markets

Europe Cell Sheet-based Gene Therapy Market Analysis and Forecast, 2025-2035 - Favorable Regulatory Framework Under EMA's Advanced Therapy Medicinal Products (ATMP) Pathway

Dublin, Oct. 31, 2025 (GLOBE NEWSWIRE) -- The "Europe Cell Sheet-based Gene Therapy Market: Focus on Technology Type, Cell-sheet Type, Source Type, Application Type, End User, and Country - Analysis...
October 01, 2025 11:15 ET | Source: Research and Markets

Genome Editing Market Report 2025: CRISPR and Beyond - Emerging Technologies Reshape Biopharmaceutical Landscape

Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The "Genome Editing: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for genome editing is...
September 16, 2025 09:12 ET | Source: Research and Markets

Genome Editing Market Forecast Report 2025-2030, with Profiles of Merck, Horizon Discovery, GenScript, Sangamo Therapeutics, Danaher, Lonza, BEX, OriGene Technologies, CRISPR Therapeutics, and More

Dublin, Sept. 16, 2025 (GLOBE NEWSWIRE) -- The "Genome Editing Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering.Genome editing, a transformative...
September 02, 2025 15:06 ET | Source: Association of American Physicians and Surgeons

Harms from Modified mRNA COVID-19 Vaccines Discussed in the Journal of American Physicians and Surgeons

While mRNA biologics are a transformative frontier, modified mRNA COVID vaccines can disrupt every body system. Urgent scrutiny and acountability needed.
August 12, 2025 04:06 ET | Source: Research and Markets

Viral Vector Vaccines Strategic Business Research Report 2025 | Market to Reach $893.2 Million by 2030 - Pandemic-Era Acceleration of Vaccine Technologies Continues to Drive Viral Vector Advancements

Dublin, Aug. 12, 2025 (GLOBE NEWSWIRE) -- The "Viral Vector Vaccines - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Viral...
August 07, 2025 09:51 ET | Source: Research and Markets

Gene Editing Research Forecasts Report 2025 | Market to Reach $22 Billion by 2033 - Key Dynamics, Opportunities, Future Road Map, Competitive Landscape and Major Trends

Dublin, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The "Gene Editing Market Size, Share, Growth, and Forecasts 2025-2033" report has been added to ResearchAndMarkets.com's offering. The global gene...
July 30, 2025 04:15 ET | Source: Research and Markets

Japan Genome Editing Market Size, Share & Trends Analysis Report 2025-2033: Japan's Genome Editing Market Set to Reach USD 1.45 Billion by 2033

Dublin, July 30, 2025 (GLOBE NEWSWIRE) -- The "Japan Genome Editing Market Size, Share & Trends Analysis Report By Technology (CRISPR/Cas9), By Delivery Method (Ex Vivo), By Application (Genetic...